迈维昂医疗系统公司与Tam Anh综合医院合作,将先进的质子治疗技术引入越南
Bridging the Gap in Cancer Care with Practical, Accessible, and High-Precision Technology
利用实用、可及且高精度的技术弥合癌症护理的差距
Littleton, Mass.--(ANTARA/Business Wire)--Mevion Medical Systems has signed a definitive purchase agreement to bring the MEVION S250-FIT Proton Therapy System™ to Tam Anh General Hospital in Vietnam. This would be the first proton therapy system in Vietnam. This signing reflects a broader shift in cancer care: proton therapy is becoming more practical to deploy, enabling more hospitals to bring advanced treatment closer to the patients who need it.
马萨诸塞州利特尔顿--(ANTARA/Business Wire)--Mevion医疗系统公司已签署了一份最终购买协议,将向越南Tam Anh综合医院引进MEVION S250-FIT质子治疗系统™。这将是越南首套质子治疗系统。此次签约反映了癌症治疗领域的一个更广泛转变:质子治疗的部署变得更加可行,使更多医院能够为需要的患者提供先进的治疗服务。
Both the MEVION S250-FIT™ and MEVION S250i Proton Therapy System® have recently received regulatory approval in Vietnam, marking an important step toward clinical implementation..
MEVION S250-FIT™ 和 MEVION S250i 质子治疗系统® 最近在越南获得了监管批准,这标志着向临床实施迈出了重要一步。
The introduction of proton therapy at Tam Anh General Hospital marks a turning point for cancer care in Southeast Asia and is facilitated by TD Tech Company, Mevion’s distributor in Vietnam. By establishing this domestic capability, Vietnam joins a growing group of countries expanding access to advanced proton therapy, ensuring that Vietnamese patients have access to world-class treatment within their own borders.
Tam Anh综合医院引入质子治疗标志着东南亚癌症护理的转折点,这一进程由TD Tech公司(Mevion在越南的经销商)推动。通过建立这种国内能力,越南加入了越来越多正在扩大先进质子治疗可及性的国家行列,确保越南患者在国内即可获得世界级的治疗。
The MEVION S250-FIT system at Tam Anh General Hospital is expected to become operational as early as late 2027, upon the inauguration of Tam Anh’s new facility in Phu My Hung, one of Vietnam’s most modern urban areas..
预计 MEVION S250-FIT 系统将在 2027 年底前于塔姆安综合医院投入使用,届时塔姆安将在越南最现代化的城市区域之一富美兴启用其新设施。
Proton therapy is widely regarded as one of the most advanced forms of radiation treatment available today. Unlike conventional photon (X-ray) radiation therapy, proton beams can precisely deposit the majority of their energy directly within the tumor while minimizing exit dose beyond the target. This level of precision reduces radiation exposure to healthy tissues and helps lessen treatment-related side effects in select clinical scenarios, particularly for complex tumors and pediatric cancers..
质子治疗被广泛认为是当今最先进的放射治疗形式之一。与传统的光子(X射线)放射治疗不同,质子束能够精确地将其大部分能量直接沉积在肿瘤内部,同时最大限度地减少对靶区以外的辐射剂量。这种精确性降低了对健康组织的辐射暴露,并有助于在特定临床情况下减轻治疗相关的副作用,特别是对于复杂肿瘤和儿童癌症。
MEVION S250-FIT™: Making Proton Therapy a Reality
MEVION S250-FIT™:让质子治疗成为现实
The cornerstone of this partnership is the
这种伙伴关系的基石是
MEVION S250-FIT
MEVION S250-FIT
, a breakthrough technology designed to make proton therapy a practical reality for hospitals worldwide. Historically, proton therapy required massive, multi-story facilities and decade-long planning cycles. The FIT™ platform changes this paradigm, enabling advanced care to be deployed with unprecedented ease:.
,一项旨在使质子治疗成为全球医院实用现实的突破性技术。历史上,质子治疗需要庞大的多层建筑设施和长达十年的规划周期。FIT™ 平台改变了这一模式,以前所未有的便捷性实现先进治疗的部署:。
Bunker-Ready Design:
地堡就绪设计:
It is the only FDA-cleared proton system designed for installation in a standard, existing radiation therapy vault.
它是唯一获得FDA批准的质子系统,专为安装在标准的现有放射治疗室中而设计。
Rapid Deployment:
快速部署:
By eliminating the need for massive new construction, the FIT allows hospitals to begin treating patients much faster than traditional systems.
通过消除对大规模新建工程的需求,FIT系统使医院能够比传统系统更快地开始治疗患者。
Operational Simplicity:
操作简便性:
The FIT system fits directly into conventional oncology workflows, using AI-driven treatment planning and integrated diagnostic CT imaging.
FIT系统直接融入传统的肿瘤学工作流程,利用人工智能驱动的治疗规划和集成的诊断CT成像。
Upright Patient Positioning:
直立患者体位:
The installation will feature an upright patient positioning system from Leo Cancer Care, providing enhanced flexibility in patient setup and a more comfortable experience for those treated in a seated position.
该装置将采用Leo Cancer Care提供的直立式患者定位系统,可增强患者设置的灵活性,并为那些以坐姿接受治疗的人提供更舒适的体验。
State-of-the-art Treatment Planning:
最先进的治疗规划:
Powered by RaySearch Laboratories, the RayStation®* treatment planning system features multi-criteria optimization, HYPERSCAN® and DirectARC™ planning, and highly accurate dose engines tailored specifically for advanced proton therapy.
由RaySearch Laboratories提供的技术支持,RayStation®* 治疗规划系统具有多准则优化、HYPERSCAN® 和 DirectARC™ 规划,以及专为先进的质子治疗量身定制的高精度剂量引擎。
Leadership Vision
领导愿景
'Our partnership with Tam Anh General Hospital marks an important step in Mevion’s mission to make the most advanced cancer care accessible to patients worldwide,' said
“我们与Tam Anh综合医院的合作标志着Mevion在使全球患者都能获得最先进的癌症治疗这一使命中迈出了重要的一步,”
Tina Yu, Ph.D., CEO and President of Mevion Medical Systems
余婷,博士,Mevion医疗系统公司首席执行官兼总裁
. 'By integrating the MEVION S250-FIT into their oncology program, Tam Anh is demonstrating how the next generation of compact proton therapy can be seamlessly adopted by leading health systems to deliver precise, life-saving treatment closer to home.'
“通过将MEVION S250-FIT整合到他们的肿瘤治疗项目中,Tam Anh展示了下一代紧凑型质子治疗如何能够被领先的医疗系统无缝采用,以在离家更近的地方提供精准、挽救生命的治疗。”
“As one of Vietnam’s leading general hospital systems in terms of clinical excellence, advanced and specialized technologies, and comprehensive services, Tam Anh has consistently taken the lead in acquiring world-class, cutting-edge medical technologies and equipment,” said Mr. Ngo Chi Dung, Chairman of the Board of Directors, Tam Anh General Hospital Group.
“作为越南在临床卓越、先进和专业化技术以及综合服务方面领先的综合医院系统之一,Tam Anh始终走在获取世界级尖端医疗技术和设备的前列,”Tam Anh综合医院集团董事长吴志勇先生表示。
“The purchase of the next-generation MEVION S250-FIT™ Proton Therapy System marks a significant milestone, not only for the Tam Anh General Hospital Group but also as a major step forward in Vietnam’s efforts to access and effectively deploy the world’s most advanced medical technologies in cancer care.
“购买下一代MEVION S250-FIT™质子治疗系统标志着一个重要的里程碑,不仅对Tam Anh综合医院集团而言如此,也是越南在获取并有效部署世界上最先进的癌症治疗医疗技术方面迈出的重要一步。
This event reaffirms Tam Anh’s strategic vision of making large-scale, comprehensive investments in healthcare in general, and oncology in particular, serving millions of Vietnamese people as well as international patients, in alignment with international standards of quality, clinical effectiveness, and patient safety.”.
该事件重申了Tam Anh的战略愿景,即在医疗保健领域进行大规模、全面的投资,尤其是在肿瘤学方面,服务数百万越南人民以及国际患者,符合国际质量、临床效果和患者安全标准。
About Mevion Medical Systems
关于Mevion医疗系统
Mevion Medical Systems is a leading provider of compact proton therapy systems for cancer care. Dedicated to advancing the design and accessibility of proton therapy worldwide, Mevion pioneered the single-room platform and continues to further the science and application of proton therapy. Since 2013, Mevion compact proton therapy single-room systems have been used by leading cancer centers for treating patients.
Mevion医疗系统公司是紧凑型质子治疗系统的领先提供商,致力于癌症治疗。该公司专注于推动全球质子治疗的设计和可及性,开创了单室平台,并继续推进质子治疗的科学和应用。自2013年以来,Mevion紧凑型质子治疗单室系统已被领先的癌症中心用于治疗患者。
Mevion’s series of products, including the flagship MEVION S250i.
Mevion系列产品,包括旗舰产品MEVION S250i。
®
®
and MEVION S250-FIT™ with HYPERSCAN
MEVION S250-FIT™ with HYPERSCAN
®
®
pencil beam scanning, represent the world’s most compact proton therapy systems that eliminate the obstacles of size, complexity, and cost. Mevion is headquartered in Littleton, Massachusetts with a presence in Europe and Asia. For more information, please visit
铅笔束扫描,是世界上最紧凑的质子治疗系统,消除了体积、复杂性和成本方面的障碍。Mevion 总部位于马萨诸塞州利特尔顿,在欧洲和亚洲也有业务。欲了解更多信息,请访问
www.mevion.com
www.mevion.com
.
。
About Tam Anh General Hospital Group
关于Tam Anh综合医院集团
Tam Anh General Hospital Group is a high-tech hospital system delivering advanced diagnostics and treatment, specialized care, and training and research meeting international standards. After a decade of development, the Tam Anh General Hospital Group has become one of Vietnam’s leading modern private healthcare systems.
Tâm Anh综合医院集团是一家高科技医院系统,提供先进的诊断和治疗、专业护理以及符合国际标准的培训和研究。经过十年的发展,Tâm Anh综合医院集团已成为越南领先的现代化私营医疗体系之一。
The system currently operates five facilities in Hanoi and Ho Chi Minh City, serving more than two million patient visits each year, including tens of thousands of international patients. For more information, please visit: .
该系统目前在河内和胡志明市运营五家医疗机构,每年接待超过两百万患者,其中包括数万名国际患者。欲了解更多信息,请访问:。
https://tamanhhospital.vn
https://塔曼医院.vn
.
。
About TD Tech Company
关于TD科技公司
Toan Dien Medical Technology Company Limited (TD Tech Company) is a medical device distributor in Vietnam with more than twenty years of experience in the field of radiation oncology. For more information, please visit:
全电医疗科技有限公司(TD Tech Company)是越南一家拥有二十多年放射肿瘤学领域经验的医疗器械经销商。欲了解更多信息,请访问:
https://xatri.vn
https://xatri.vn
.
。
*RaySearch products are subject to regulatory clearance in some markets.
*RaySearch 产品在某些市场需获得监管许可。
Contacts
联系人
Media Contact:
媒体联系人:
Jacqueline Abner-Pongratz
杰奎琳·阿布纳-蓬格拉茨
Jacqueline.Pongratz@Mevion.com
杰奎琳·庞格拉茨@米维昂公司
Source: Mevion Medical Systems
来源:Mevion医疗系统
Reporter: PR Wire
记者:PR Wire
Editor: PR Wire
编辑:PR Wire
Copyright © ANTARA 2026
版权 © ANTARA 2026
